Literature DB >> 837364

Evaluation of estrogen receptor assays in human breast cancer tissue.

W L McGuire, M De La Garza, G C Chamness.   

Abstract

Standard dextran-coated charcoal (DCC) and sucrose gradient centrifugation assays for estrogen receptor were compared in a series of human breast cancer tissues. From a quantitative standpoint the results were remarkably similar. A simplified version of the DCC assay compared to the sucrose gradient assay yielded acceptable results. We conclude that, in spite of the lack of specificity controls inherent in the sophisticated standard assays, the simplified DCC assay might be useful if the biopsy specimen is too small to provide the number of aliquots for a standard DCC assay or sufficient protein for a sucrose gradient analysis. It also might be useful in research laboratories attempting to develop assays for multiple receptors or other constituents in a single tumor biopsy specimen.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 837364

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  45 in total

1.  Steroid hormone receptor levels and adjuvant tamoxifen in early breast cancer. Ten year results of the Naples (GUN) Study.

Authors:  S De Placido; C Gallo; A Marinelli; F Perrone; C Pagliarulo; G Petrella; G Delrio; M D'Istria; L Del Mastro; A R Bianco
Journal:  Breast Cancer Res Treat       Date:  1990-09       Impact factor: 4.872

2.  Reverse transcription-polymerase chain reaction (RT-PCR) assays of estrogen and progesterone receptors in breast cancer.

Authors:  S Chevillard; A Müller; C Levalois; C Lainé-Bidron; P Vielh; H Magdelénat
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

3.  Selectivity of polyamine involvement in hormone action on normal and neoplastic target tissues of the rat.

Authors:  A Manni; B Badger; J Lynch; L Demers
Journal:  Breast Cancer Res Treat       Date:  1991 Jan-Feb       Impact factor: 4.872

4.  Immunohistochemical studies on oncogene products (c-erbB-2, EGFR, c-myc) and estrogen receptor in benign and malignant breast lesions. With special reference to their prognostic significance in carcinoma.

Authors:  K Tauchi; S Hori; H Itoh; R Y Osamura; Y Tokuda; T Tajima
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

5.  Steroid receptors in breast cancer: sources of inter-laboratory variation in dextran-charcoal assays.

Authors:  S M Thorpe
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

Review 6.  Extranuclear signaling by sex steroid receptors and clinical implications in breast cancer.

Authors:  Viroj Boonyaratanakornkit; Nalo Hamilton; Diana C Márquez-Garbán; Prangwan Pateetin; Eileen M McGowan; Richard J Pietras
Journal:  Mol Cell Endocrinol       Date:  2017-11-14       Impact factor: 4.102

7.  Pharmacoclinical data on high dose medroxyprogesterone acetate in advanced breast cancer.

Authors:  M Namer; G Milano; R Khater; M Frenay; A Thyss; N Renée
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

8.  Correlation of aromatase activity with histological differentiation of breast cancer--a morphometric analysis.

Authors:  A Lipton; R J Santen; S J Santner; H A Harvey; D White-Hershey; M J Bartholomew; F E Sharkey
Journal:  Breast Cancer Res Treat       Date:  1988-09       Impact factor: 4.872

9.  Biological differences among MCF-7 human breast cancer cell lines from different laboratories.

Authors:  C K Osborne; K Hobbs; J M Trent
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

10.  Epidermal growth factor receptor expression in breast cancer association with biologic phenotype and clinical outcomes.

Authors:  Mothaffar F Rimawi; Priya B Shetty; Heidi L Weiss; Rachel Schiff; C Kent Osborne; Gary C Chamness; Richard M Elledge
Journal:  Cancer       Date:  2010-03-01       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.